10x Genomics, Inc. (TXG) Net margin 2017–2025
10x Genomics, Inc. (TXG) net profit margin by fiscal year — reported net income divided by reported revenue.
-6.8%FY2025 · since FY2017: -26.4% → -6.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6.8% | +23.1 pp |
| FY2024 | -29.9% | +11.3 pp |
| FY2023 | -41.2% | -9.1 pp |
| FY2022 | -32.1% | -20.3 pp |
| FY2021 | -11.9% | +169.7 pp |
| FY2020 | -181.6% | -168.9 pp |
| FY2019 | -12.7% | +64.2 pp |
| FY2018 | -76.9% | -50.5 pp |
| FY2017 | -26.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice